PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
19.94%
Positive growth while USLM shows revenue decline. John Neff would investigate competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
19.94%
Gross profit growth exceeding 1.5x USLM's 3.23%. David Dodd would verify competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-363.75%
EBITDA decline while USLM shows 18.75% growth. Joel Greenblatt would examine position.
-319.90%
EBITDA margin decline while USLM shows 43.11% growth. Joel Greenblatt would examine position.
-363.75%
Operating income decline while USLM shows 50.00% growth. Joel Greenblatt would examine position.
-319.90%
Operating margin decline while USLM shows 80.77% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-19.11%
Tax expense reduction while USLM shows 0.00% growth. Joel Greenblatt would examine advantage.
19.11%
Net income growth while USLM declines. John Neff would investigate advantages.
-0.69%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-100.00%
EPS decline while USLM shows 1.25% growth. Joel Greenblatt would examine position.
-100.00%
Diluted EPS decline while USLM shows 1.25% growth. Joel Greenblatt would examine position.
-100.00%
Share count reduction while USLM shows 3.16% change. Joel Greenblatt would examine strategy.
-100.00%
Diluted share reduction while USLM shows 3.16% change. Joel Greenblatt would examine strategy.